Ambu updates its fiscal 2025/26 financial outlook guidance
The company expects around ten percent organic revenue growth and an EBIT margin between twelve and fourteen percent, driven primarily by its Endoscopy Solutions segment.
See the latest news and media coverage for Ambu. We track all announcements, press releases, and industry mentions in real time, all in one place.
Manufacturer of single-use medical devices
ambu.comLast updated
In short: Ambu grew Q3 revenue 8.8 percent and won clearances for pediatric and lower GI endoscopy
The company expects around ten percent organic revenue growth and an EBIT margin between twelve and fourteen percent, driven primarily by its Endoscopy Solutions segment.
Organic revenue grows 7.3% to DKK 1,573m. EBIT margin is 11.0%. Updates FY guidance to 10-12% organic growth. Announces DKK 300m share buyback.
Results show 8.6% organic revenue growth and 10.5% EBIT margin. They launch ZOOM AHEAD strategy for global endoscopy leadership.
Achieves double-digit growth, outperforms benchmarks, launches ZOOM AHEAD strategy. Supports care for over 100 million patients worldwide.
Ambu stock is attempting to regain footing after a late-August guidance cut, with Q3 2026 earnings showing revenue growth, higher EPS and stronger margins despite...
In the third quarter, Ambu delivered a profit of 156 million kroner. This is shown by the quarterly financial figures. Danish Ambu opened its accounts for the year on Tuesday evening...
In the third quarter, Ambu delivered a profit of 156 million kroner. This is shown by the quarterly financial figures. The Danish company Ambu, which sells hospital equipment to the whole...
Ambu A/S reported strong organic growth in its Q2 2026 earnings call, despite facing significant...
Track Ambu and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Ambu and other trending companies.